PHATHOM PHARMACEUTICALS INC (PHAT) Stock Analyst Ratings
USA - NASDAQ:PHAT - US71722W1071 - Common Stock
14.36 USD
+0.63 (+4.59%)
14.36 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 84% to PHAT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.8. This target is 51.83% above the current price.
PHAT was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PHAT.
In the previous month the buy percentage consensus was at a similar level.
PHAT was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-09 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-06-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-06 | Needham | Maintains | Buy -> Buy |
| 2025-05-02 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-02 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-05-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-21 | Needham | Reiterate | Buy -> Buy |
| 2025-04-17 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-04-02 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-02 | Needham | Reiterate | Buy -> Buy |
| 2025-03-10 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-06 | Needham | Reiterate | Buy -> Buy |
| 2025-01-10 | Needham | Reiterate | Buy -> Buy |
| 2024-12-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-11 | Needham | Reiterate | Buy -> Buy |
| 2024-09-13 | Needham | Reiterate | Buy -> Buy |
| 2024-09-06 | Needham | Reiterate | Buy -> Buy |
| 2024-08-30 | Needham | Reiterate | Buy -> Buy |
| 2024-08-23 | Needham | Reiterate | Buy -> Buy |
| 2024-08-19 | Needham | Reiterate | Buy -> Buy |
| 2024-08-12 | Needham | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-07-26 | Needham | Reiterate | Buy -> Buy |
| 2024-07-22 | Needham | Reiterate | Buy -> Buy |
| 2024-07-19 | Needham | Reiterate | Buy -> Buy |
| 2024-07-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
PHATHOM PHARMACEUTICALS INC / PHAT FAQ
What is the price target for PHAT stock?
15 analysts have analysed PHAT and the average price target is 21.8 USD. This implies a price increase of 51.83% is expected in the next year compared to the current price of 14.36.
How do analysts rate PHATHOM PHARMACEUTICALS INC (PHAT)?
The consensus rating for PHATHOM PHARMACEUTICALS INC (PHAT) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for PHATHOM PHARMACEUTICALS INC stock?
The number of analysts covering PHATHOM PHARMACEUTICALS INC (PHAT) is 15.